Filarial nematode secreted product ES-62 is an anti-inflammatory agent: Therapeutic potential of small molecule derivatives and ES-62 peptide mimetics

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 5-6, 2006, Pages 511-518

  Harnett, William ^a   Harnett, Margaret M ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ES 62; Filarial nematodes; Inflammation; Signal transduction

Indexed keywords

ANTIINFLAMMATORY AGENT; B LYMPHOCYTE ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHORYLCHOLINE; PROTEIN ES 62; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; B LYMPHOCYTE ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; HUMAN; INFLAMMATION; MACROPHAGE; NEMATODE; NONHUMAN; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; DENDRITIC CELLS; FILARIOIDEA; HELMINTH PROTEINS; HUMANS; MACROPHAGES; MOLECULAR MIMICRY; PHOSPHORYLCHOLINE; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33745191896     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04400.x     Document Type: Review

References (92)

1. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989 299 : 1259 60.
2. Sewell DL, Reinke EK, Hogan LH, Sandor M, Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett. 2002 82 : 101 10.
3. Beighton P, Solomon L, Valkenburg HA. Rheumatoid arthritis in a rural South African Negro population. Ann. Rheum. Dis. 1975 34 : 136 41.
4. Dunne DW, Cooke A. A worm's eye view of the immune system: Consequences for evolution of human autoimmune disease. Nat. Rev. Immunol. 2005 5 : 420 6.
5. Maizels RM. Infections and allergy: Helminths, hygiene and host immune regulation. Curr. Opin. Immunol. 2005 17 : 656 61.
6. World Health Organization. Filariasis. WHO, Geneva. 2000.
7. Subramanian S, Stolk WA, Ramaiah KD et al. The dynamics of Wuchereria bancrofti infection: A model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004 128 : 467 82.
8. King CL. Transmission intensity and human immune responses to lymphatic filariasis. Parasite Immunol. 2001 23 : 363 71.
9. Brattig NW. Pathogenesis and host responses in human onchocerciasis: Impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect. 2004 6 : 113 28.
10. Harnett W, Grainger M, Kapil A, Worms MJ, Parkhouse RME. Origin, kinetics of circulation and fate in vivo of the major excretory-secretory product of Acanthocheilonema viteae. Parasitol. Today 1989 99 : 229 39.
11. Stepek G, Auchie M, Tate R et al. Expression of the filarial nematode phosphorylcholine-containing glycoprotein, ES62, is stage specific. Parasitology 2002 125 : 155 64.
12. Stepek G, Houston KM, Goodridge HS, Devaney E, Harnett W. Stage-specific and species-specific differences in the production of the mRNA and protein for the filarial nematode secreted product, ES-62. Parasitol. Today 2004 128 : 91 8.
13. Harnett W, Harnett MM. Inhibition of murine B cell proliferation and down-regulation of protein kinase C levels by a phosphorylcholine-containing filarial excretory-secretory product. J. Immunol. 1993 151 : 4829 37.
14. Harnett MM, Deehan MR, Williams DM, Harnett W. Induction of signalling anergy via the T-cell receptor in cultured Jurkat T cells by pre-exposure to a filarial nematode secreted product. Parasite Immunol. 1998 20 : 551 63.
15. Wilson EH, Katz E, Goodridge HS, Harnett M, Harnett W. In vivo activation of murine peritoneal B1 cells by the filarial nematode phosphorylcholine- containing glycoprotein ES-62. Parasite Immunol. 2003 25 : 463 6.
16. Whelan M, Harnett MM, Houston KM, Patel V, Harnett W, Rigley KP. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 2000 164 : 6453 60.
17. Goodridge HS, Wilson EH, Harnett W, Campbell CC, Harnett MM, Liew FY. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J. Immunol. 2001 167 : 940 5.
18. Houston KM, Wilson EH, Eyres L et al. Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-10-dependent mechanism. Infect. Immun. 2000 68 : 5466 8.
19. Marshall FA, Garside P, Harnett W, Harnett MM. ES-62, an immunomodulator secreted by filarial nematodes suppresses clonal expansion and skews effector function of heterologous antigen-specific T cells in vivo. J. Immunol. 2005 175 : 5817 26.
20. Ronnelid J, Berg L, Rogberg S, Nilsson A, Albertsson K, Klareskog L. Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: Enhanced activity in synovial fluid compared to blood. Br. J. Rheumatol. 1998 37 : 7 14.
21. Chabaud M, Durand JM, Buchs N et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999 42 : 963 70.
22. Gracie JA, Forsey RJ, Chan WL et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 1999 104 : 1393 401.
23. Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. Curr. Opin. Immunol. 2001 13 : 611 16.
24. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996 14 : 397 440.
25. McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY, Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J. Immunol. 2003 171 : 2127 33.
26. McInnes IB, Gracie JA, Harnett M, Harnett W, Liew FY. New strategies to control inflammatory synovitis: Interleukin 15 and beyond. Ann. Rheum Dis. 2003 62 ( Suppl. 2 51 4.
27. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 1992 89 : 9784 8.
28. Harnett W, Harnett MM, Leung BP, Gracie JA, McInnes IB. The anti-inflammatory potential of the filarial nematode secreted product, ES-62. Curr. Top. Med. Chem. 2004 4 : 553 9.
29. Harnett W, McInnes IB, Harnett MM. ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potential. Immunol. Lett. 2004 94 : 27 33.
30. Goodridge HS, Deehan MR, Harnett W, Harnett MM. Subversion of immunological signalling by a filarial nematode phosphorylcholine-containing secreted product. Cell Signal. 2005 17 : 11 16.
31. Goodridge HS, Stepek G, Harnett W, Harnett MM. Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62. Immunology 2005 115 : 296 304.
32. Gauld SB, Dal Porto JM, Cambier JC. B cell antigen receptor signaling: Roles in cell development and disease. Science 2002 296 : 1641 2.
33. Harnett MM, Katz E, Ford CA. Differential signalling during B-cell maturation. Immunol. Lett. 2005 98 : 33 44.
34. Harnett W, Houston KM, Amess R, Worms MJ. Acanthocheilonema viteae: Phosphorylcholine is attached to the major excretory-secretory product via an N-linked glycan. Exp. Parasitol. 1993 77 : 498 502.
35. Deehan M, Harnett M, Harnett W. A filarial nematode secreted product differentially modulates expression and activation of protein kinase C isoforms in B lymphocytes. J. Immunol. 1997 159 : 6105 11.
36. BrickGhannam C, Ericson ML, Schelle I, Charron D. Differential regulation of mRNAs encoding protein kinase C isoenzymes in activated human B cells. Hum. Immunol. 1994 41 : 216 24.
37. Francis DA, Karras JG, Ke XY, Sen R, Rothstein TL. Induction of the transcription factors NF-kappaB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 1995 7 : 151 61.
38. Hornbeck P, Huang KP, Paul WE. Lamin B is rapidly phosphorylated in lymphocytes after activation of protein kinase C. Proc. Natl Acad. Sci. USA 1988 85 : 2279 83.
39. Klemsz MJ, Justement LB, Palmer E, Cambier JC. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 1989 143 : 1032 9.
40. Mittelstadt PR, DeFranco AL. Induction of early response genes by crosslinking membrane Ig on B lymphocytes. J. Immunol. 1993 150 : 4822 32.
41. Seyfert VL, McMahon S, Glenn W, Cao X, Sukhatme VP, Monroe JG. Egr-1 expression in surface Ig-mediated B cell activation. J. Immunol. 1990 145 : 3647 53.
42. Deehan MR, Frame MJ, Parkhouse RM et al. A phosphorylcholine-containing filarial nematode-secreted product disrupts B lymphocyte activation by targeting key proliferative signaling pathways. J. Immunol. 1998 160 : 2692 9.
43. Deehan MR, Harnett W, Harnett MM. A filarial nematode-secreted phosphorylcholine-containing glycoprotein uncouples the B cell antigen receptor from extracellular signal-regulated kinase-mitogen-activated protein kinase by promoting the surface Ig-mediated recruitment of Src homology 2 domain-containing tyrosine phosphatase-1 and Pac-1 mitogen-activated kinase-phosphatase. J. Immunol. 2001 166 : 7462 8.
44. Goodridge HS, Harnett W, Liew FY, Harnett MM. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses. Immunology 2003 109 : 415 25.
45. Goodridge HS, Marshall FA, Wilson EH et al. In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 2004 113 : 491 8.
46. Goodridge HS, Marshall FA, Else KJ et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 2005 174 : 284 93.
47. Babu S, Nutman TB. Proinflammatory cytokines dominate the early immune response to filarial parasites. J. Immunol. 2003 171 : 6723 32.
48. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003 21 : 335 76.
49. Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J. Biol. Chem. 2003 278 : 41 43 51.
50. Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004 4 : 499 511.
51. Belladonna ML, Renauld JC, Bianchi R et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 2002 168 : 5448 54.
52. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 13 : 715 25.
53. Devergne O, Hummel M, Koeppen H et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes [published erratum appears in J. Virol. 1996; 70: 2678]. J. Virol. 1996 70 : 1143 53.
54. Gillessen S, Carvajal D, Ling P et al. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur. J. Immunol. 1995 25 : 200 6.
55. Ling P, Gately MK, Gubler U et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 1995 154 : 116 27.
56. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 1997 94 : 12 41 6.
57. Lauwerys BR, Van Snick J, Houssiau FA. Serum IL-12 in systemic lupus erythematosus: Absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 2002 11 : 384 7.
58. Gran B, Zhang GX, Yu S et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002 169 : 7104 10.
59. Wiekowski MT, Leach MW, Evans EW et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 2001 166 : 7563 70.
60. Harnett W, Harnett MM, Byron O. Structural/functional aspects of ES-62: A secreted immunomodulatory phosphorylcholine-containing filarial nematode glycoprotein. Curr. Protein Peptide Sci. 2003 4 : 59 71.
61. Harnett W, Houston KM, Tate R et al. Molecular cloning and demonstration of an aminopeptidase activity in a filarial nematode glycoprotein. Mol. Biochem. Parasitol. 1999 104 : 11 23.
62. Taylor A. Aminopeptidases: Towards a mechanism of action. Trends Biochem. Sci. 1993 18 : 167 71.
63. Acosta D, Goni F, Carmona C. Characterization and partial purification of a leucine aminopeptidase from Fasciola hepatica. J. Parasitol. 1998 84 : 1 7.
64. Ackerman CJ, Harnett MM, Harnett W, Kelly SM, Svergun DI, Byron O. 19 Å solution structure of the filarial nematode immunomodulatory protein, ES-62. Biophys. J. 2003 84 : 489 500.
65. Harnett W, Harnett MM. Phosphorylcholine: Friend or foe of the immune system? Immunol. Today 1999 20 : 125 9.
66. Walton KA, Cole AL, Yeh M et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 1197 203.
67. Walton KA, Hsieh X, Gharavi N et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 2003 278 : 29 61 6.
68. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 2003 278 : 1561 8.
69. Haslam SM, Khoo KH, Houston KM, Harnett W, Morris HR, Dell A. Characterisation of the phosphorylcholine-containing N-linked oligosaccharides in the excretory-secretory 62 kDa glycoprotein of Acanthocheilonema viteae. Mol. Biochem. Parasitol. 1997 85 : 53 66.
70. Bodman-Smith KB, Melendez AJ, Campbell I, Harrison PT, Allen JM, Raynes JG. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). Immunology 2002 107 : 252 60.
71. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv. Immunol. 1994 57 : 1 127.
72. Kean DE, Melendez AJ, McSharry C, Harnett MM, Harnett W. A potential therapeutic for the filarial nematode secreted product ES-62 in asthma. Immunology 2004 113 ( Suppl. 1 60 (Abstract).
73. Deehan MR, Goodridge HS, Blair D et al. Immunomodulatory properties of Ascaris suum glycosphingolipids: Phosphorylcholine and non-phosphorylcholine- dependent effects. Parasite Immunol. 2002 24 : 463 9.
74. Kean DE, Ohtsuka I, Sato K et al. Dissecting Ascaris glycosphingolipids for immunomodulatory moieties: The use of synthetic structural glycosphingolipid analogues. Parasite Immunol. 2006 28 : 69 76.
75. Borghouts C, Kunz C, Groner B. Current strategies for the development of peptide-based anti-cancer therapeutics. J. Peptide Sci. 2005 11 : 713 26.
76. Mendoza FJ, Espino PS, Cann KL, Bristow N, McCrea K, Los M. Anti-tumor chemotherapy utilizing peptide-based approaches: Apoptotic pathways, kinases, and proteasome as targets. Arch. Immunol. Ther. Exp. 2005 53 : 47 60.
77. Burke Jr TR, Yao ZJ, Liu DG, Voigt J, Gao Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers 2001 60 : 32 44.
78. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000 289 : 1550 4.
79. Rehman KK, Bertera S, Bottino R et al. Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem. 2003 278 : 9862 8.
80. Nagel-Wolfrum K, Buerger C, Wittig I, Butz K, Hoppe-Seyler F, Groner B. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol. Cancer Res. 2004 2 : 170 82.
81. Kim MY, Byeon CW, Hong KH, Han KH, Jeong S. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide. FEBS Lett. 2005 579 : 1597 601.
82. Burke Jr TR, Smyth MS, Otaka A et al. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. Biochemistry 1994 33 : 6490 4.
83. Burke Jr TR, Nomizu M, Otaka A et al. Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding. Biochem. Biophys. Res. Commun. 1994 201 : 1148 53.
84. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death. Diabetes 2001 50 : 77 82.
85. Barr RK, Boehm I, Attwood PV, Watt PM, Bogoyevitch MA. The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK. J. Biol. Chem. 2004 279 : 36 27 38.
86. Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK. Targeting the JNK MAPK cascade for inhibition: Basic science and therapeutic potential. Biochim. Biophys. Acta 2004 1697 : 89 101.
87. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994 269 : 10 44 50.
88. Fawell S, Seery J, Daikh Y et al. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 1994 91 : 664 8.
89. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF. Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res. 2001 61 : 474 7.
90. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 1999 285 : 1569 72.
91. Mi Z, Mai J, Lu X, Robbins PD. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2000 2 : 339 47.
92. Mi Z, Lu X, Mai JC et al. Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol. Ther. 2003 8 : 295 305.